TNDM Tandem Diabetes Care, Inc. Loading...

From PODD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Feb 18 ◎
Ashley McEvoy CEO, Insulet Corporation PODD Q4 FY25 call
Insulet is pivoting sales messaging to emphasize clinical performance (A1C reduction) as a counter to competitive claims, while maintaining its form-factor and user-experience edge. — Enhanced clinical pitch could protect market share against tube pump competitors and sustain growth from new MDI converts.
TNDM
MED

About TNDM Analyst Coverage

Buzzberg tracks TNDM (Tandem Diabetes Care, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Ashley McEvoy.